Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 139 results found. Search for [ generic assets ]

Results 120 to 139 of 139
Shalini S. Dagar
February 14, 2012
Business Today's maiden listing of India's PE and VC funds coincides with a change imperative in the industry.


www.businesstoday.in
December 21, 2011
In a breather for corporate executives embroiled in the 2G scam, the Supreme Court nod led to a spate of bail applications being accepted.


E. Kumar Sharma
September 14, 2011
Next year, Glenmark Pharma is likely to have half a dozen compounds in Phase II human trials. Chairman Glenn Saldanha hopes to hit the market with one or more of his drugs between 2015 and 2017. This potential upside is precisely why Glenmark is in Business Today's listing of Tomorrow's Goliaths.SPECIAL: India Inc's rising star companies Other 7 companies in the list:IndiGo | Fortis | Lanco Infratech | Cafe Coffee Day | Nuclear Power Corporation | Axis Bank | iGate


Team BT
January 4, 1998
For the family-owned business group, the future hinges on the ability to combine strategic and operational excellence with a constant willingness to change. BT presents a theoretical exposition of how the survival prospects of the family business can be evaluated. A framework.


R Shree Ram
August 26, 2010
A Money Today-value research study of the stocks that mutual fund managers stacked up over the past one year.


www.businesstoday.in
November 25, 2010
Citius, Altius, Fortius' could well be the rallying cry of the rupee as it rises swiftly, touches new highs and becomes stronger against the dollar.


ITGD Bureau
Mumbai, October 18, 2010
Indian stocks were trading lower on Monday, in line with the weakness in Asian markets. All the sector indices were in the red, with automobile and FMCG being weighed down the most.


R. Sree Ram
January 22, 2009
Investing in select pharma stocks might be the shot in the arm that your portfolio needs in times of a slowdown. The general environment for the pharma industry, particularly for domestic companies, seems positive.


www.businesstoday.in
July 11, 2008
As the inflation rate moves up, key market indices are spiralling downward. Is there a way of making sure that your portfolio is not affected by this rising rate?


Tanvi Varma/Money Today
January 23, 2008
Like IT, most pharma funds have underperformed in a booming market. What should the investor do right now — sell, hold or buy? Here are some answers.


Devangshu Datta
December 24, 2007
Using a simple style, this ambitious book aims to help lay investors overcome their fear of learning the basics of mutual funds. Though targeted at a US audience the book is useful to Indian readers too.


www.businesstoday.in
May 3, 2007
This selection of research reports gives information and opinions on companies and industries.They are often filled with jargon, which we must reluctantly inflict on readers sincethe excerpts are verbatim. Seven such terms occur in these extracts: EBITDA = EarningsBefore Interest,Tax, Depreciation,Amortisation, EV = Enterprise Value, EPS = Earnings Per Share, PE = Price-Earnings, PAT/PBT = Profit After/ Before Tax,YoY = Year-on-year.


E. Kumar Sharma
June 9, 2010
Piramal's domestic formulations business becomes the latest—and most expensive—acquisition of an Indian drug business by a global pharma major. As the stakes get higher, who's next?


www.businesstoday.in
January 11, 2010
The Orchid Chemicals and Pharmaceuticals and Hospira Inc. deal for the purchase of the former's generic injectable pharmaceuticals business will benefit both parties.


Virendra Verma
November 15, 2009
The pharma high flier has been hammered by derivative losses and is choking on a mountain of debt. The good news: Some deft financial restructuring has given both promoter and industry hope.


www.businesstoday.in
August 21, 2008
M&M eyes more auto segments, and more markets. he company is likely to launch the Scorpio in the US through a Georgiabased distributor named Global Vehicles.


www.businesstoday.in
July 8, 2008
Risen: By 38.6 per cent, direct tax collections during the first quarter of 2008-09, to Rs 57,373 crore, compared to 28 per cent and Rs 41,391 crore for the corresponding period last year.


T.V. Mahalingam
June 10, 2008
A year ago in late May 2007, Mumbai-headquartered Sun Pharma, together with its subsidiaries, had signed 'definitive agreements' to acquire Taro Pharmaceutical Industries, a multinational manufacturer of generic pharmaceuticals. A year later, the transaction is in tatters and both parties are washing dirty linen in public. Why? T.V. Mahalingam finds out the reasons.


Brian Carvalho
December 23, 2007
On the fringes of Mumbai, in what’s known as Navi or New Mumbai, lies Mahape. One of the 226-odd functional industrial areas chalked out by the Maharashtra Industrial Corporation (MIDC) in the state is sprawled over this suburb.


Shalini S. Dagar
November 13, 2007
Taking advantage of an upbeat economy the central government has launched or revamped major schemes aimed at rural India. But have they really worked for the aam aadmi? Shalini S. Dagar finds out.


PAGES 7 OF 7  67